ArticleMolecular and clinical oncology2015

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study.

Matthieu Caubet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.